BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 22, 2025
Home
»
Topics
»
Regulatory
» EMA
EMA
RSS
Negative opinion handed down for Valdoxan/Thymanax in Europe
Aug. 3, 2006
Positive opinion handed down in Europe for Ganfort
March 28, 2006
Alcon withdraws European submission for Retaane
March 3, 2006
Alcon withdraws application to extend European approval of Opatanol
Feb. 28, 2006
February meeting of European Committee for Orphan Medicinal Products
Feb. 18, 2005
Positive opinion for new Thyrogen indication in Europe
Jan. 27, 2005
EMEA warns on new safety findings for valdecoxib, parecoxib sodium
Dec. 27, 2004
EMEA warns on coadministration of Reyataz and Norvir with omeprazole
Dec. 27, 2004
CHMP adopts extension of indication for Schering-Plough HCV products
Oct. 27, 2004
E.U. regulators to review long-term cardiovascular safety data for COX-2 inhibitors
Oct. 13, 2004
Previous
1
2
…
148
149
150
151
152
153
154
155
156
Next